Called New Delhi metallobeta-lactamase, or NDM-1 for short, the enzyme destroys carbapenems, an important group of antibiotics used for difficult infections in hospitals, and has been found in a wide variety of bacterial types.

Although there is no threat to the U.S as of the yet, the developement of new antibiotics to fight superbugs has come to a halt.

If these bugs spread we are certainly at risk for a disaster and a threat to modern medicine as we know it.

Read the full article for all the details.

Some experts warn health-care provision is in danger of reverting back to a pre-antibiotic era in which hip replacements, care of preterm babies and advanced cancer treatment are no longer possible.

Abuse of antibiotic use in helthcare and livestock has increased superbug resistance to these therapies.